| Annual Financials | 2025 | TTM |
Revenue  | 112 | 0 |
| Expenses | 98 | 0 |
| EBITDA | 14 | 0 |
| Operating Profit % | 8 % | 0 % |
| Depreciation | 1 | 0 |
| Interest | 2 | 0 |
| Profit Before Tax | 11 | 0 |
| Tax | 2 | 0 |
| Net Profit | 8 | 0 |
| EPS in ₹ | 7.70 | 0.00 |
Hemant Surgical Industries
Hemant Surgical Industries
289.25
+13.75
(4.99%)
Market Cap
₹377.13 Cr
PE Ratio
44.65
Volume
6,400.00
Day High - Low
₹289.25 - ₹275.50
52W High-Low
₹367.10 - ₹88.15
Key Fundamentals
Market Cap
377.13 Cr
EPS
7.70
PB Ratio
3.14
Book Value
87.71
EBITDA
14.10
Dividend Yield
0.00 %
Industry
Healthcare Sector
Medical Equipment ROE Growth %
-
Debt to Equity
0.49
Actual
Company News
View All News
Hemant Surgical Industries Reports No Deviation in IPO Fund UtilizationNov 12, 2025
Hemant Surgical Industries Limited reported no deviation or variation in the utilization of funds raised through its Initial Public Offer dated May 31, 2023, for the half year ended September 30, 2025. The company's IPO proceeds totaling INR 2,483.00 lakhs were allocated across four categories: Public Issue Expenses (INR 313.88 lakhs), Working Capital Requirements (INR 1,000.00 lakhs), Capital Expenditure for installation (INR 751.26 lakhs), and General Corporate Purposes (INR 418.86 lakhs). All fund allocations remain unchanged from their original purposes with no modifications reported. Managing Director Hanskumar Shamji Shah signed the compliance statement filed with BSE Limited.
Hemant Surgical Industries Reports Strong Half-Year Results with Revenue Growth and Share Capital Raise
Nov 12, 2025
Nov 12, 2025Hemant Surgical Industries Limited announced its unaudited financial results for the half year ended September 30, 2025. The company reported revenue from operations of ₹64.26 crores compared to ₹48.87 crores in the previous corresponding period. Basic earnings per share stood at ₹5.09 versus ₹3.05 in the prior year period. The company raised ₹61.53 crores through preferential allotment of 25,98,400 equity shares at ₹197 per share and issued 20,99,200 convertible warrants. Out of total proceeds of ₹92.54 crores allocated for various purposes, the company has utilized ₹15.43 crores, with ₹46.09 crores currently in bank accounts and ₹31.02 crores yet to be received from warrant holders. The funds are intended for capital expenditure towards new facilities expansion, augmenting working capital needs, and debt repayment.
Hemant Surgical Industries Allots 600,000 Warrants to Promoters Through Preferential AllotmentSep 22, 2025
Sep 22, 2025Hemant Surgical Industries Limited has allotted 600,000 warrants convertible into equity shares to its promoters and promoter group on September 16, 2025. The warrants were distributed equally among three promoters: Hanskumar Shamji Shah, Hemant Praful Shah, and Kaushik Hanskumar Shah, with each receiving 200,000 warrants. Each warrant can be converted into one fully paid-up equity share with a face value of Rs. 10 within 18 months from the allotment date. Following this allotment, the promoter group's total holding increased to 86,80,000 shares, representing 64.67% of the total voting capital. The company's equity share capital after the acquisition stands at Rs. 13,03,84,000 comprising 1,30,38,400 equity shares, while the total diluted share capital reaches Rs. 15,13,76,000 with 1,51,37,600 equity shares.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,889.80 | #1 19,148.53 | 52.73 | #1 1,759.00 | 22.62 | #1 339 | 5.03 | 46.53 | |
267.25 | 1,468.86 | 56.10 | 242.40 | 24.12 | 25 | 44.07 | 40.25 | |
228.56 | 1,216.08 | 59.20 | 408.40 | 32.64 | 30 | -67.96 | 40.36 | |
239.08 | 1,062.73 | #1 23.13 | 335.90 | 45.66 | 47 | 751.52 | 53.40 | |
599.55 | 1,060.88 | 53.21 | 186.60 | 40.62 | 20 | - | 34.54 | |
592.00 | 984.01 | 65.32 | 249.37 | 43.89 | 17 | -14.81 | 48.66 | |
328.95 | 626.32 | 37.23 | 136.30 | #1 107.77 | 16 | - | 55.53 | |
469.95 | 564.10 | 28.61 | 67.10 | 13.15 | 18 | 14.58 | 50.36 | |
289.25 | #9 377.13 | #4 44.65 | #9 111.80 | - | #9 8 | - | 54.05 | |
297.45 | 297.46 | 75.88 | 122.10 | 19.24 | 1 | #1 820.00 | 56.94 |
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
-84.54 %
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2025 |
| Total Assets | 148 |
| Fixed Assets | 40 |
| Current Assets | 89 |
| Capital Work in Progress | 12 |
| Investments | 0 |
| Other Assets | 97 |
| Total Liabilities | 148 |
| Current Liabilities | 61 |
| Non Current Liabilities | 24 |
| Total Equity | 63 |
| Reserve & Surplus | 53 |
| Share Capital | 10 |
Cash Flow
| Cash Flow | 2025 |
| Net Cash Flow | -4 |
| Investing Activities | -30 |
| Operating Activities | 9 |
| Financing Activities | 18 |
Share Holding
| % Holding | Jun 2023 | Sept 2023 | Mar 2024 | Sept 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 73.56 % | 73.56 % | 73.56 % | 73.56 % | 73.56 % | 58.90 % | 58.90 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.39 % | 0.15 % | 0.15 % |
| DIIs | 0.49 % | 0.00 % | 1.97 % | 1.13 % | 1.11 % | 10.81 % | 10.81 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 11.00 % | 17.47 % | 20.64 % | 20.24 % | 20.87 % | 23.17 % | 23.22 % |
| Others | 14.94 % | 8.97 % | 3.82 % | 5.07 % | 4.06 % | 6.97 % | 6.91 % |
| No of Share Holders | 830 | 722 | 1,229 | 1,248 | 1,229 | 748 | 758 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 25 Sept 2024 |  Annual General Meeting | NA | 25 Sept 2024 | 160.50 | 154.50 |
| 13 Nov 2024 |  Quarterly Result Announcement | NA | 13 Nov 2024 | 147.00 | 146.55 |
| 28 May 2025 | Quarterly Result Announcement | NA | 28 May 2025 | 106.00 | 105.00 |
| 30 Aug 2025 |  Extraordinary General Meeting | NA | 30 Aug 2025 | 234.00 | 292.00 |
| 23 Sept 2025 | Annual General Meeting | NA | 23 Sept 2025 | 290.70 | 352.65 |
| 12 Nov 2025 | Quarterly Result Announcement | NA | 12 Nov 2025 | 290.00 | 290.00 |
Announcements
Statement Of Deviation Or Variation Pursuant To Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 12, 2025
Nov 12, 2025Statement Of Deviation Or Variation Pursuant To Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 12, 2025
Nov 12, 2025Un-Audited Financial Results Of The Company For The Half Year Ended On September 30 2025.Nov 12, 2025
Nov 12, 2025Board Meeting Outcome for Held On Wednesday November 12 2025Nov 12, 2025
Nov 12, 2025Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results Of The Company For Half Year Ended On September 30 2025Nov 05, 2025
Nov 05, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 13, 2025
Oct 13, 2025Closure of Trading WindowSep 27, 2025
Sep 27, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 23, 2025
Sep 23, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 23, 2025
Sep 23, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 22, 2025
Sep 22, 2025Announcement under Regulation 30 (LODR)-AllotmentSep 18, 2025
Sep 18, 2025Announcement under Regulation 30 (LODR)-AllotmentSep 16, 2025
Sep 16, 2025Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderSep 11, 2025
Sep 11, 2025Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportSep 01, 2025
Sep 01, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMAug 30, 2025
Aug 30, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 30, 2025
Aug 30, 2025Dispatch Of Letter To ShareholdersAug 29, 2025
Aug 29, 2025Reg. 34 (1) Annual Report.Aug 29, 2025
Aug 29, 2025Notice Of The 36Th Annual General Meeting (AGM) Of The Company To Be Held On September 23 2025Aug 29, 2025
Aug 29, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 29, 2025
Aug 29, 2025Intimation For 36Th Annual General Meeting Scheduled To Be Held On Tuesday September 23 2025.Aug 28, 2025
Aug 28, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateAug 28, 2025
Aug 28, 2025 Intimation Of Appointment Of Secretarial Auditor Cost Auditor And Internal Auditor.Aug 28, 2025
Aug 28, 2025Board Meeting Outcome for Held On Thursday August 28 2025Aug 28, 2025
Aug 28, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 11, 2025
Aug 11, 2025Dispatch Of Letter To Shareholders Whose E-Mail Addresses Are Not Registered With Company/Registrar & Transfer Agent/Depository ParticipantsAug 08, 2025
Aug 08, 2025Notice Of An Extra-Ordinary General Meeting Of The CompanyAug 08, 2025
Aug 08, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 07, 2025
Aug 07, 2025Board Meeting Outcome for Held On Wednesday August 06 2025Aug 06, 2025
Aug 06, 2025Closure of Trading WindowAug 01, 2025
Aug 01, 2025Board Meeting Intimation for To Consider Proposal For Fund RaisingAug 01, 2025
Aug 01, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 09, 2025
Jul 09, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2025
May 30, 2025Statement Of Deviation & VariationMay 28, 2025
May 28, 2025Audited Results For Half And Financial Year Ended March 31 2025May 28, 2025
May 28, 2025Board Meeting Outcome for Held On Wednesday May 28 2025May 28, 2025
May 28, 2025Board Meeting Intimation for Approval Of Audited Financial Results Of The Company For Half And Financial Year Ended On March 31 2025.May 16, 2025
May 16, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 28, 2025
Apr 28, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Apr 08, 2025Closure of Trading WindowMar 27, 2025
Mar 27, 2025Announcement under Regulation 30 (LODR)-Updates on AcquisitionMar 13, 2025
Mar 13, 2025Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015Feb 24, 2025
Feb 24, 2025Compliances-Certificate Under Reg. 74(5) Of SEBI (Depositories And Participants) Regulations 2018 For The Quarter Ended December 31 2024.Jan 13, 2025
Jan 13, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateJan 02, 2025
Jan 02, 2025Intimation For Change Of Corporate Identification Number (CIN) And Company Status Of Hemant Surgical Industries Limited ('The Company') On MCA Website.Dec 11, 2024
Dec 11, 2024Statement Of Deviation For The Period Ended On September 30, 2024Nov 13, 2024
Nov 13, 2024Un-Audited Financial Results Of The Company For The Half Year Ended On September 30, 2024.Nov 13, 2024
Nov 13, 2024Board Meeting Outcome for The Meeting Held On Wednesday, November 13, 2024Nov 13, 2024
Nov 13, 2024Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Will Be Held On Wednesday, November 13, 2024.Nov 05, 2024
Nov 05, 2024Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations, 2015Oct 10, 2024
Oct 10, 2024Technical Indicators
RSI(14)
Neutral 54.05
ATR(14)
Volatile 10.61
STOCH(9,6)
Neutral 71.10
STOCH RSI(14)
Neutral 66.36
MACD(12,26)
Bullish 1.91
ADX(14)
Strong Trend 28.23
UO(9)
Bearish 55.36
ROC(12)
Uptrend And Accelerating 9.15
WillR(14)
Neutral -20.48
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
